Former FDA Deputy To Pay $127,496 For Insider Trading Role Involving Generics

Mealey's (November 29, 2016, 9:40 AM EST) -- NEW YORK — A former Food and Drug Administration deputy director turned industry lobbyist was enjoined Nov. 14 from violating the Securities Exchange Act for his role in giving FDA insider information to a hedge fund manager who reportedly made millions from the scheme (Securities and Exchange Commission v. Sanjay Valvani, et al., No. 16-4512, S.D. N.Y.)....

Attached Documents

Related Sections